Terray Therapeutics CEO Jacob Berlin (L) and CFO and COO Eli Berlin
October 12, 2022 07:04 AM EDTUpdated 08:24 AM
Deals
AI

Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

Paul Schloesser

Associate Editor

A small Cal­i­for­nia biotech emerged from stealth last year to go af­ter drug dis­cov­ery’s “da­ta prob­lem,” and now the AI out­fit has an­nounced its first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times